Langerhans cell histiocytosis (LCH) can affect children and adults with a wide variety of
clinical manifestations, including unifocal, single-system multifocal, single-system pulmonary …

Langerhans cell histiocytosis (LCH) is a rare systemic disorder characterized by the
accumulation of CD 1a+/Langerin+ LCH cells and wide‐ranging organ involvement …

Background Langerhans cell histiocytosis (LCH) is a rare histiocytic disorder of unknown
etiopathogenesis. Its clinical presentation is variable and ranges from isolated skin or bone …

Introduction: Langerhans cell histiocytosis (LCH) is a heterogeneous disease, involving the
accumulation of langerhans cells in various organs. The physician's perception of the …

Adult Langerhans cell histiocytosis (LCH) remains poorly defined. We retrospectively
studied 266 newly diagnosed LCH patients to understand the clinical presentation …

These guidelines for the management of patients up to 18 years with Langerhans cell
histiocytosis (LCH) have been set up by a group of experts involved in the Euro Histio Net …

Abstract Langerhans Cell Histiocytosis (LCH) is an orphan disease of clonal dendritic cells
which may affect any organ of the body. Most of the knowledge about the diagnosis and …

Children with Langerhnans cell histiocytosis (LCH) develop granulomatous lesions with
characteristic clonal CD207+ dendritic cells that can arise as single lesions or life …

Langerhans cell histiocytosis (LCH) is caused by clonal expansion of myeloid precursors
that differentiate into CD1a+/CD207+ cells in lesions that leads to a spectrum of organ …

Langerhans cell histiocytosis (LCH) may affect patients of any age but in adults the features
of this disease are still poorly defined. Most reports are based on single-specialty …